| Application no. and date | 21798552.2 (espacenet) (Federated) (European Patent Register), 20211013 | | Patent/reg. no. and date | DK/EP 4228753, 20250730 | | Publication date | 20230823 | | Priority no. and date | WO PCT/CN2020/120814, 20201014 | | EP pub. no. and date |
EP 4228753 20230823 | | Effective date | | | Applicant/owner | Qilu Regor Therapeutics Inc., Building 10
No. 1206, Zhangjiang Road
Shanghai 201210, CN | | Applicant ref. no. | | | Inventor | ZHONG, Wenge,
Thousand Oaks, California 91362, US,
GUO, Wei,
Shanghai 201210, CN,
LI, Zheng Jane,
Sherman, CT 06784, US,
JIANG, Xiawei,
Hangzhou Bay New Area
Ningbo, Zhejiang 315336, CN,
CHEN, Pengyuan,
Hangzhou Bay New Area
Ningbo, Zhejiang 315336, CN | | Representative | | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61P 3/10 (2006.01) , C07D 405/14 (2006.01) | | Title | CRYSTAL FORMS OF GLP-1R AGONISTS AND USES THEREOF | | Int. application no. | CN2021123387 | | Int. publication no. | WO2022078352 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
